Plain-English translation of NCT06834191 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers believe inflammation may play a role in Parkinson's disease. This study is investigating whether immune-suppressing medications—drugs that calm down the body's inflammatory response—might slow down how quickly Parkinson's symptoms develop or worsen. The study will compare people with Parkinson's who regularly take these medications for other conditions with people who don't take them.
Recent research has found high levels of inflammation-related markers in people with Parkinson's disease. Scientists want to understand whether reducing inflammation through medication could help slow the disease's progression, which could eventually lead to better treatment options.
You likely qualify if…
You likely don't qualify if…
You will attend one appointment at the hospital lasting about an hour. During this visit, you'll have your Parkinson's symptoms assessed by the research team (you'll skip your Parkinson's medication that morning so they can see your baseline symptoms), complete some symptom questionnaires, have one blood sample taken, and answer detailed questions about your medical history—especially any medications you take that suppress your immune system.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Poland